Senior Director, Scientific Collaborations

BioReference Laboratories
Job Location
Elmwood Park, NJ 07407
Job Description
  • Lead a team responsible for supporting the scientific research and analysis behind the identification of pharma research collaborations as well as actively participate in those projects / collaborations.
  • Assist in the preparation of presentation materials that discuss our Genomics expertise in specific therapeutic areas and presenting that work to pharma research and executive leadership teams
  • Work with your team, as well as internal geneticists, genetic counselors and laboratory bioinformatics staff to identify novel targets for therapeutics and/or drug repurposing opportunities 
  • Support external partnerships in research, clinical development, technology / content and with vendors and industry organizations
  • Ideal candidate can either be based in NNJ/NYC or Boston, MA area.
  • Ability to travel both nationally and internationally (approximately 20%)
  • Ph.D. in the Life Sciences (preferably Bioinformatics, Biology, Genetics or Medicinal Chemistry)
  • Experience working in drug discovery at a biopharma / pharma company, Medical Institution or Disease Foundation supporting drug discovery, target validation, drug repurposing, clinical development projects
  • Strong genomics, bioinformatics or systems biology experience and understanding of available tools, data sources and computational methods.
  • Eligible USA work permit
  • Excellent team leadership, interpersonal, organizational, presentation and communication skills
  • Highly motivated with strong decision-making capacity and desire to make a difference in the world
  • Ability to work effectively as a senior team member in a matrixed, multi-site environment
  • Exceptional attention to detail
About Our Organization

BioReference Laboratories, established in 1981, is the third largest diagnostic laboratory in the world and a member of the OPKO Health, Inc. (NYSE: OPK) group of companies with more than $1B in revenues for 2015.  Our GeneDx business is a world leader in Genomics with an acknowledged expertise in rare and ultra-rare genetic disorders, as well as one of the broadest menus of sequencing services available among commercial laboratories.  GeneDx performs more clinical Whole Exome Sequencing tests than any other diagnostic lab in the world and is the leading commercial contributor to the ClinVar variant database. The GeneDx mission is to make clinical testing affordable and available to people with rare genetic conditions and their families and GeneDx provides testing to patients and their families in more than 55 countries.   In 2015, our GeneDx business had revenues of $175M, provided testing to more than 100,000 patients and discovered more than two dozen novel gene / disease associations.

In 2015, we formed a new business, Commercial Collaborations and Innovation, to leverage our vast genomics expertise, disease understanding and accumulated information across our businesses so we could go beyond just helping patients or families diagnose the condition of a loved one.  Our goal is to use our knowledge in a responsible manner to help support the discovery and development of novel therapeutic agents that can be better targeted to a specific disease through the genomics knowledge we possess. Our business unit supporting precision medicine is unlike any other genomics-driven business in the world because of the information and expertise we have, particularly in the area of rare and ultra-rare diseases.   This position is a pivotal member of the team, which also includes business development, marketing and informatics professionals.

Students whose classmates are interested in science are more likely to think about a career in science, technology, engineering, and mathematics, a new study says.

CNBC reports that the genetic counseling field is expected to grow as personalized medicine becomes more common.

Gladys Kong writes at Fortune that her STEM background has helped her as a CEO.

Social scientists report that the image of the 'lone scientist' might be deterring US students from STEM careers.